Generic lenacapavir for HIV prevention moves closer to India with CDSCO waiver of local Phase 3 trials - ThePrint

Generic lenacapavir for HIV prevention moves closer to India with CDSCO waiver of local Phase 3 trials  ThePrintDRL, Emcure get approval to make breakthrough HIV drug  The Economic TimesIndia’s HIV infections are rising quietly. Why twice-yearly lenacapavir matters  India TodayIndia regulator recommends waivers for twice yearly lenacapavir injection trials  NewsBytes